Prospect News: News for Regeneron Pharmaceuticals Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with R > Issuers starting with R, BK only > All stories on Regeneron Pharmaceuticals Inc. > Stories on Regeneron Pharmaceuticals Inc., BK only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Regeneron Pharmaceuticals Inc.

1/5/2024	BKIG	Moody’s boosts Regeneron
2/23/2023	BKIG	Moody's upgrades Regeneron
12/20/2022	BK	Regeneron enters replacement $750 million five-year revolver
7/5/2022	BKIG	Moody's views Regeneron positively
8/7/2020	BKIG	Moody’s rates Regeneron notes Baa3
8/7/2020	BKIG	S&P rates Regeneron notes BBB+
8/5/2020	BKIG	S&P gives Regeneron BBB+
8/5/2020	BKIG	Moody’s assigns Baa3 to Regeneron
12/17/2018	BK	Regeneron gets $750 million five-year revolver at Libor plus 125 bps
3/23/2015	BK	Regeneron gets $750 million five-year revolver at Libor plus 125 bps

©2026 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.